Trial Profile
Pilot Study of Metformin (MF) IN HNSCC (Head and Neck Squamous Cell Carcinoma) as Window Trial Design in Operable HNSCC, to Investigate the Effects of MF, Tumor Genotype and MF Genotype Interactions, on Tumor Metabolism and Anoikis
Status:
Discontinued
Phase of Trial:
Phase 0
Latest Information Update: 09 Aug 2018
Price :
$35
*
At a glance
- Drugs Metformin (Primary)
- Indications Head and neck cancer; Squamous cell cancer
- Focus Therapeutic Use
- 08 Nov 2016 Status changed from recruiting to discontinued because Funding was not available and PI left institution.
- 07 Apr 2015 New trial record